Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment uptake of patients with chronic hepatitis C: can we expect and do more?

Literature DB >> 20976622

Treatment uptake of patients with chronic hepatitis C: can we expect and do more?

Chia-Yen Dai.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2010 PMID： 20976622 DOI： 10.1007/s10620-010-1452-6

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

31 in total

1. Diagnosis, management, and treatment of hepatitis C.

Authors: Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal: Hepatology Date: 2004-04 Impact factor: 17.425

2. The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.

Authors: Jee-Fu Huang; Ming-Lung Yu; Chung-Feng Huang; Chang-Fu Chiu; Chia-Yen Dai; Ching-I Huang; Ming-Lun Yeh; Jeng-Fu Yang; Ming-Yen Hsieh; Nai-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Liang-Yen Wang; Wan-Long Chuang
Journal: J Hepatol Date: 2010-09-07 Impact factor: 25.083

3. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.

Authors: Stefan Wirth; Carmen Ribes-Koninckx; Maria Angeles Calzado; Flavia Bortolotti; Lucia Zancan; Paloma Jara; Mark Shelton; Nanda Kerkar; Marcela Galoppo; Alejandra Pedreira; Norberto Rodriguez-Baez; Mirta Ciocca; Alain Lachaux; Florence Lacaille; Thomas Lang; Ulrike Kullmer; Wolf Dietrich Huber; Teresita Gonzalez; Henry Pollack; Estella Alonso; Pierre Broue; Jyoti Ramakrishna; Deborah Neigut; Antonio Del Valle-Segarra; Bessie Hunter; Zachery Goodman; Christine R Xu; Hanzhe Zheng; Stephanie Noviello; Vilma Sniukiene; Clifford Brass; Janice K Albrecht
Journal: J Hepatol Date: 2010-02-04 Impact factor: 25.083

4. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors: M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal: Lancet Date: 2001-09-22 Impact factor: 79.321

5. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin.

Authors: Manuel Romero-Gómez; Moisés Diago; Raúl J Andrade; José L Calleja; Javier Salmerón; Conrado M Fernández-Rodríguez; Ricard Solà; Javier García-Samaniego; Juan M Herrerías; Manuel De la Mata; Ricardo Moreno-Otero; Oscar Nuñez; Antonio Olveira; Santiago Durán; Ramón Planas
Journal: Hepatology Date: 2009-12 Impact factor: 17.425

Review 6. Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections.

Authors: Chun-Jen Liu; Jyh-Ming Liou; Ding-Shinn Chen; Pei-Jer Chen
Journal: J Formos Med Assoc Date: 2005-11 Impact factor: 3.282

7. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors: Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal: Ann Intern Med Date: 2004-03-02 Impact factor: 25.391

Review 8. Treatment of chronic hepatitis C in Asia: when East meets West.

Authors: Ming-Lung Yu; Wan-Long Chuang
Journal: J Gastroenterol Hepatol Date: 2009-03 Impact factor: 4.029

9. Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.

Authors: Chung-Feng Huang; Jeng-Fu Yang; Chia-Yen Dai; Jee-Fu Huang; Nai-Jen Hou; Ming-Yen Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang; Ming-Lung Yu
Journal: J Infect Dis Date: 2010-03 Impact factor: 5.226